AJTMH ASTMH MEMBERSHIP INFORMATION: astmh@astmh.org
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am. J. Trop. Med. Hyg., 57(6), 1997, pp. 646-650
Copyright © 1997 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Parzy, D.
Right arrow Articles by Doury, J.-C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Parzy, D.
Right arrow Articles by Doury, J.-C.

Proguanil Resistance in Plasmodium falciparum African Isolates: Assessment by Mutation-Specific Polymerase Chain Reaction and in Vitro Susceptibility Testing

Daniel Parzy, Christian Doerig, Bruno Pradines, Alain Rico, Thierry Fusai AND Jean-Claude Doury
Institut de Medecine Tropicale du Service de Sante des Armees, Marseille, France; Institut de la Sante et de la Recherche Medicale, Unite 399, Faculte de Medecine, Marseille, France

The antifolate proguanil is commonly used in the prophylaxis and treatment of Plasmodium falciparum malaria. A series of point mutations in the dihydrofolate reductase (DHFR) gene has been linked to differential susceptibility of varied P. falciparum clones or isolates to this drug. To survey the efficiency of proguanil prophylaxis in an African endemic region, and to evaluate the level of proguanil resistance in the corresponding parasite population, we performed drug susceptibility assays with P. falciparum isolates from Senegal, Kenya, and Niger. In parallel, we developed a mutation-specific polymerase chain reaction assay that enabled us to characterize mutations in the DHFR gene of the same isolates without in vitro parasite cultivation. We confirm previously available data showing that parasites harboring a point mutation from Ser 108 to Asn present a decrease in susceptibility to cycloguanil (the active metabolite of proguanil), and we show that mutations in codons 51 and 59 appear to modulate the level of resistance to cycloguanil. No mutations in codons 16 and 164 were detected in resistant parasites, in contrast with results from some previous studies.




This article has been cited by other articles:


Home page
Am J Trop Med HygHome page
H. TINTO, J. B. OUEDRAOGO, I. ZONGO, C. VAN OVERMEIR, E. VAN MARCK, T. R. GUIGUEMDE, and U. D'ALESSANDRO
SULFADOXINE-PYRIMETHAMINE EFFICACY AND SELECTION OF PLASMODIUM FALCIPARUM DHFR MUTATIONS IN BURKINA FASO BEFORE ITS INTRODUCTION AS INTERMITTENT PREVENTIVE TREATMENT FOR PREGNANT WOMEN
Am J Trop Med Hyg, April 1, 2007; 76(4): 608 - 613.
[Abstract] [Full Text] [PDF]


Home page
Am J Trop Med HygHome page
M. HENRY, I. DIALLO, J. BORDES, S. KA, B. PRADINES, B. DIATTA, P. S. M'BAYE, M. SANE, M. THIAM, P. M. GUEYE, et al.
Urban malaria in dakar, senegal: chemosusceptibility and genetic diversity of Plasmodium falciparum isolates.
Am J Trop Med Hyg, July 1, 2006; 75(1): 146 - 151.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the American Society of Tropical Medicine and Hygiene.